About this trial
The goal of this prospective observational study is to evaluate the role of ultrasound-guided tru-cut biopsy (in the hands of an expert certified sonographer within a gynecological center)in patients with suspected ovarian cancer.
The main questions it aims to answer are:
Is the material from tru-cut biopsy adequate for histopathological and immunohistochemical examination? Is the material accurate in comparison with the final pathological specimen? What are the patient experience and complications after the procedure?
Participants who will undergo a standard tru-cut biopsy procedure will need to additionally answer the questionnaire.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
suspected advanced ovarian cancer
indication for tru-cut biopsy by multidisciplinary oncoboard
Disqualifiers
patient deny to undergo tru-cut biopsy
Trial population
Patients with suspected advanced ovarian cancer
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Adequacy of tru-cut biopsy in ovarian cancer
Evaluation of the adequacy of the procedure in diagnosing ovarian cancer by histopathological and immunohistochemical examination.
Secondary outcomes
Accuracy of tru-cut biopsy in ovarian cancer
Evaluation of accuracy between tru-cut biopsy and definitive histology in ovarian cancer.
Other outcomes
Patient assesment
To evaluate the patient experience with tru-cut biopsy and to record complications.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.